Becker's Healthcare December 27, 2022
Congress passed an end-of-year bill Dec. 23 that includes withdrawing a federal barrier to pharmacists prescribing an opioid overdose treatment and numerous strategies to manage persistent drug supply problems.
Four things to know from the proposed legislation:
1. One provision would remove the FDA’s “X waiver” from buprenorphine, meaning that pharmacists who are authorized to dispense controlled substances and have at least eight hours of training for treating and managing patients with substance use disorders could prescribe the opioid dependence therapy.
2. It directs HHS to identify incentives that would achieve increased domestic...
Today's Sponsors
Today's Sponsor